Skip to main content

Table 1 Characteristics of the patients with ESBL-E bacteremia

From: Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study

Demographics  
 Men 270 (62.5)
 Age (mean, range) 70.3, 0-96 y
 Age > 65 y 280 (72.4)
Place of acquisition
 Community acquired 110 (28.4)
 Health care associated bacteremia 137 (35.4)
 Nosocomial 140 (36.2)
Origin of infection
 Urinary 215 (55.3)
 Biliary 49 (12.7)
 Unknown 37 (9.6)
 Intra-abdominal 34 (8.8)
 Pneumonia 28 (7.2)
 Catheter 16 (4.1)
 Other 8 (2.1)
Comorbidity
Diabetes 112 (28.9)
Cancer 111 (28.7)
Ictus 70 (18.1)
Dementia 66 (17.1)
Immunosuppression 65 (16.8)
COPD 65 (17.1)
Chronic renal failure 68 (17.6)
Cardiac failure 56 (14.5)
Liver cirrhosis 44 (11.4)
Metastatic tumor 33 (8.5)
Charlson ≥3 209 (54)
  1. Date are no. (%) of patients; COPD: chronic obstructive pulmonary disease.